These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 4260263

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intestinal decarboxylation of L-Dopa in relation to dose requirement in Parkinson's disease.
    Granerus AK, Jagenburg R, Svanborg A.
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 280(4):429-39. PubMed ID: 4274706
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Absorption and metabolism of L-dopa by the human stomach.
    Rivera-Calimlim L, Dujovne CA, Morgan JP, Lasagna L, Bianchine JR.
    Eur J Clin Invest; 1971 May; 1(5):313-20. PubMed ID: 5558777
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. L-dopa level in plasma, primary condition for the kinetic effect.
    Birkmayer W, Danielcyk W, Neumayer E, Riederer P.
    J Neural Transm; 1973 May; 34(2):133-43. PubMed ID: 4722571
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Abnormalities in 14 CO 2 production from DL-3,4-dihydroxyphenylalanine-carboxyl- 14 C in schizophrenia and parkinsonism: a preliminary report.
    Tran-Manh N, Laplante M, Saint-Laurent J, LeBel E.
    Rev Can Biol; 1972 May; 31():Suppl:255-62. PubMed ID: 5052327
    [No Abstract] [Full Text] [Related]

  • 17. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). I. Autoradiographic study on the distribution of 14 C-labeled D- and L-DOPA and dopamine after intravenous administration in rats.
    Shindo H, Miyakoshi N, Takahashi I.
    Chem Pharm Bull (Tokyo); 1971 Dec; 19(12):2490-500. PubMed ID: 5145918
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of amantadine on L-2-14C-dopa metabolism in parkinsonism.
    Peaston MJ, Bianchine JR, Messiha FS.
    Life Sci; 1973 Aug 16; 13(3):237-46. PubMed ID: 4750920
    [No Abstract] [Full Text] [Related]

  • 20. Metabolic studies and clinical observations during L-dopa treatment of Parkinson's disease.
    Peaston MJ, Bianchine JR.
    Br Med J; 1970 Feb 14; 1(5693):400-3. PubMed ID: 5434658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.